Methoctramine induces nonspecific airway hyperresponsiveness in vivo

European Journal of Pharmacology
R E HowellK Laemont

Abstract

We investigated the effects of subtype-selective muscarinic receptor antagonists upon aerosol antigen-induced bronchoconstriction in anesthetized guinea pigs. Neither pirenzepine (muscarinic M1 receptor-selective), 4-methylpiperidine methiodide (4-DAMP, muscarinic M3 receptor-selective), [N-iminomethyl-N'-[(2-hydroxy-2-phenyl-2-cyclohexyl)-ethyl] piperazine HCl (DAC-5945, muscarinic M3 receptor-selective), ipratropium or atropine inhibited bronchoconstriction, but methoctramine (muscarinic M2 receptor-selective) produced a dose-dependent increase in bronchoconstriction (up to 46%). Methoctramine also produced increases in bronchoconstriction induced by aerosols of histamine (up to 45%) and platelet activating factor (up to 118%), demonstrating nonspecific airway hyperresponsiveness. This effect of methoctramine was not inhibited by atropine, DAC-5945 or vagotomy and could not be attributed to altered arachidonic acid metabolism or beta-adrenergic antagonism. However, propranolol prevented methoctramine-induced airway hyperresponsiveness, suggesting that this effect resulted from the reported ganglionic blocking activity of methoctramine. In conclusion, muscarinic receptors do not appear to play an important role in antigen-indu...Continue Reading

Citations

Jun 8, 1978·Nature·R FantozziT Bani-Sacchi
Jan 1, 1979·Annual Review of Pharmacology and Toxicology·J B Hook, M D Bailie
Jan 21, 1992·European Journal of Pharmacology·C R Killingsworth, N E Robinson
Feb 14, 1991·European Journal of Pharmacology·Z J Yang, D F Biggs
Sep 4, 1991·European Journal of Pharmacology·M J PostA J Porsius
Apr 24, 1991·European Journal of Pharmacology·R E HowellL Noronha-Blob
May 2, 1991·European Journal of Pharmacology·R E HowellL Noronha-Blob
Sep 1, 1990·British Journal of Pharmacology·P Aas, J Maclagan
May 1, 1990·British Journal of Pharmacology·R MichelettiA Donetti
Feb 1, 1989·The American Review of Respiratory Disease·J W LammersP J Barnes
Sep 13, 1989·European Journal of Pharmacology·P J Hollingsworth, C B Smith
May 19, 1989·European Journal of Pharmacology·J C Mak, P J Barnes
Jan 1, 1988·Pharmacology & Therapeutics·F Mitchelson
Sep 1, 1972·The Journal of Experimental Medicine·M KalinerK F Austen
May 1, 1984·The American Review of Respiratory Disease·N J Gross, M S Skorodin
Dec 1, 1984·British Journal of Pharmacology·A D Fryer, J Maclagan
May 1, 1993·British Journal of Pharmacology·J GarssenF P Nijkamp

Related Concepts

Histamine Measurement
N-iminomethyl-N'-((2-hydroxy-2-phenyl-2-cyclohexyl)ethyl)piperazine hydrochloride
Piperazine
Phenyl
Cavia
Flaxedil
Piperazines
Arachidonic Acid Metabolic Process
Methoctramine
Ipratropium

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.